Finoriq research workspace
BIO-RAD LABORATORIES, INC. (BIO) SEC Filings & Filing Highlights
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research. Review BIO SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
- Company
- BIO-RAD LABORATORIES, INC. (BIO)
- Ticker
- BIO
- Market Cap
- $8.1B
- Latest Price
- $303.56
- Industry
- Life Science Tools
BIO-RAD LABORATORIES, INC. (BIO) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for BIO-RAD LABORATORIES, INC. (BIO).
| Event | Form | Date |
|---|---|---|
| Bio-Rad Reports First-Quarter 2026 Financial ResultsBio-Rad Reports First-Quarter 2026 Financial Results | 8-K7.01 | 2026-04-30 |
| Bio-Rad Reports First-Quarter 2026 Financial ResultsBio-Rad Reports First-Quarter 2026 Financial Results | 8-K2.02 | 2026-04-30 |
| The Company held its Annual Meeting of Stockholders on April 21, 2026. The matters voted upon a...The Company held its Annual Meeting of Stockholders on April 21, 2026. The matters voted upon at the meeting and the results of those votes... | 8-K5.07 | 2026-04-24 |
| On April 21, 2026, at the annual meeting of stockholders (the “Annual Meeting”) of Bio-Rad Labo...On April 21, 2026, at the annual meeting of stockholders (the “Annual Meeting”) of Bio-Rad Laboratories, Inc. (the “Company”), as further d... | 8-K5.02 | 2026-04-24 |
| Investment in Sartorius AGBio-Rad Laboratories, Inc. (“Bio-Rad”) hereby provides the following update on information disclosed under the heading “Investment in Sarto... | 8-K7.01 | 2026-02-19 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.